Literature DB >> 24920326

Vocal outcome after endoscopic thyroarytenoid myoneurectomy in patients with adductor spasmodic dysphonia.

Sachin Gandhi1, Marc Remacle, Prasun Mishra, Vrushali Desai.   

Abstract

Spasmodic dysphonia (SD) remains one of the most difficult of laryngeal pathologies to treat. With limited role for speech therapy, various surgical modalities have been tried with various success rates. The objective of the study is to report the results of vocal outcome after thyroarytenoid myoneurectomy in patients of adductor spasmodic dysphonia (ASD). 15 patients of ASD were selected. GRBAS, and voice handicap index (VHI) were used for perceptual evaluation of voice. Thyroarytenoid myoneurectomy was performed by vaporizing the muscular layer of the vocal fold with CO2 laser, at an intensity of 6 W with 1.2 mm diameter in scanner mode. Voice analysis was repeated at 12, 24 and 48 months follow-up. Preoperative GRBAS scores and VHI score of all the patients were poor. At 12 months 12/15 (80 %) patients having strain score of 0. There was marked improvement in VHI scores at 6 months. 10/15 (67 %) patients have been followed up for 24 months. 5/10 (50 %) patients have strain (S) value of 0. VHI scoring of 5/10 (50 %) patients was <30. Two of the four patients completed 48 months follow-up had a strain (S) value of 0, one patient has strain value of 1 and one patient had strain value of 2. 2/4 patients had VHI score of <30; one patient had that of 40. Trans-oral CO2 laser thyroarytenoid myoneurectomy shows significant long-term improvement in voice quality in terms of reduced speech brakes, effort and strain in voice.

Entities:  

Mesh:

Year:  2014        PMID: 24920326     DOI: 10.1007/s00405-014-3129-9

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  18 in total

1.  Recurrent laryngeal nerve pathology in spasmodic dysphonia.

Authors:  J V Bocchino; H M Tucker
Journal:  Laryngoscope       Date:  1978-08       Impact factor: 3.325

2.  Recurrent laryngeal nerve section for spastic dysphonia.

Authors:  H H Dedo
Journal:  Ann Otol Rhinol Laryngol       Date:  1976 Jul-Aug       Impact factor: 1.547

3.  Laryngeal framework surgery in the management of spasmodic dysphonia. Preliminary report.

Authors:  H M Tucker
Journal:  Ann Otol Rhinol Laryngol       Date:  1989-01       Impact factor: 1.547

4.  Electromyographic assessment of spasmodic dysphonia patients prior to botulinum toxin injection.

Authors:  A A Rodriquez; C N Ford; D M Bless; R L Harmon
Journal:  Electromyogr Clin Neurophysiol       Date:  1994 Oct-Nov

5.  Selective lateral laser thyroarytenoid myotomy for adductor spasmodic dysphonia.

Authors:  A Hussain; M Shakeel
Journal:  J Laryngol Otol       Date:  2010-04-29       Impact factor: 1.469

6.  Task specificity in adductor spasmodic dysphonia versus muscle tension dysphonia.

Authors:  Nelson Roy; Manon Gouse; Shannon C Mauszycki; Ray M Merrill; Marshall E Smith
Journal:  Laryngoscope       Date:  2005-02       Impact factor: 3.325

7.  Transoral laser ventricular fold resection and thyroarytenoid myoneurectomy for adductor spasmodic dysphonia: long-term outcome.

Authors:  Chih-Ying Su; Chi-Chih Lai; Pei-Yin Wu; Hsun-Hsien Huang
Journal:  Laryngoscope       Date:  2010-02       Impact factor: 3.325

8.  Effects of voicing and syntactic complexity on sign expression in adductor spasmodic dysphonia.

Authors:  Molly L Erickson
Journal:  Am J Speech Lang Pathol       Date:  2003-11       Impact factor: 2.408

9.  Treatment of adductor-type spasmodic dysphonia by surgical myectomy: a preliminary report.

Authors:  Jamie A Koufman; Catherine J Rees; Stacey L Halum; David Blalock
Journal:  Ann Otol Rhinol Laryngol       Date:  2006-02       Impact factor: 1.547

10.  Impact in vocal quality in partial myectomy and neurectomy endoscopic of thyroarytenoid muscle in patients with adductor spasmodic dysphonia.

Authors:  Domingos Hiroshi Tsuji; Fernanda Silveira Chrispim; Rui Imamura; Luiz Ubirajara Sennes; Adriana Hachiya
Journal:  Braz J Otorhinolaryngol       Date:  2006 Mar-Apr
View more
  1 in total

Review 1.  Chemodenervation of the Larynx.

Authors:  Rachel Kaye; Andrew Blitzer
Journal:  Toxins (Basel)       Date:  2017-11-02       Impact factor: 4.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.